Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05238025
What this trial is testing

MVA-BN-RSV Vaccine Trial

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 20,419
Large-scale testing (Phase 3)Study completedNCT06710925
What this trial is testing

A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 315
Not applicableStudy completedNCT05572658
What this trial is testing

Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 10,994
Early research (Phase 1)Study completedNCT01909843
What this trial is testing

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Who this might be right for
Respiratory Syncytial Virus Infection
Ablynx, a Sanofi company 24
Large-scale testing (Phase 3)Study completedNCT05070546
What this trial is testing

An Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Janssen Vaccines & Prevention B.V. 1,124
Not applicableStudy completedNCT04623047
What this trial is testing

Infection Watch Study

Who this might be right for
COVID-19 Respiratory InfectionRespiratory Syncytial Virus InfectionsRhinoviral Infections+1 more
Duke University 10,034
Early research (Phase 1)Study completedNCT04065698
What this trial is testing

Pharmacokinetics and Safety of RV521 Formulations

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 9
Not applicableStudy completedNCT03919591
What this trial is testing

RSV Study in Adults 60 to 75 Years of Age

Who this might be right for
RSV Infection
Hvivo 24
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Early research (Phase 1)Study completedNCT03755778
What this trial is testing

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 72
Early research (Phase 1)UnknownNCT02958540
What this trial is testing

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

Who this might be right for
Respiratory Syncytial Viral Infections
Mucosis BV 48
Early research (Phase 1)Not Yet RecruitingNCT06287450
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Early research (Phase 1)Study completedNCT05873764
What this trial is testing

Learn About Effect of Sisunatovir in Healthy Adult Male Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 9
Testing effectiveness (Phase 2)Study completedNCT02534350
What this trial is testing

Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus (RSV)
Gilead Sciences 61
Early research (Phase 1)Study completedNCT05397223
What this trial is testing

Modified mRNA Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2Seasonal InfluenzaRespiratory Syncytial Virus+1 more
ModernaTX, Inc. 308
Testing effectiveness (Phase 2)Study completedNCT02753413
What this trial is testing

Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 102
Testing effectiveness (Phase 2)Ended earlyNCT01432080
What this trial is testing

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Who this might be right for
Respiratory Tract InfectionsBronchiolitis ObliteransCryptogenic Organizing Pneumonia+1 more
Maisonneuve-Rosemont Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT05655182
What this trial is testing

BLB-201 RSV Vaccine in Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 137
Testing effectiveness (Phase 2)Ended earlyNCT04225897
What this trial is testing

Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Who this might be right for
Respiratory Syncytial Virus (RSV)Lower Resp Tract Infection
Pfizer 51
Next Page